Scientific Programme Wednesday 1 September 2021

ESVIM/ISCAID abstracts

Magret Hosie (UK)
SARS-CoV-2 infections in cats: assessing their zoonotic potential and role in sustaining the COVID-19 pandemic 

Ludovic Pelligand (UK)
PopPK of amoxicillin-clavulanic acid in dogs

Regina Hofmann-Lehmann (CH)
COVID-19 in a One-Health Context: Natural SARS-CoV-2 infection in animals and its implication for infection control

Adrian Boswood (UK)
B2 stage and biomarkers (NT-proBNP) - Hamlet study

10.30-11.15

BREAK 

Sandra Felten (DE)
How to diagnose FIP, FCoV infection and SARS-CoV-2 infection in cats

Jonathan Elliott (UK)
Identification of early and progressive CKD patients - how can biomarkers be used most effectively ?

Saverio Paltrinieri (I)
Clinicopathological changes in cats with FIP and SARS-CoV-2 infection compared to people with SARS-CoV-2 infection

Ronette Gehring (NL) & Carl Ekstrand (SE)
PKPD for clinicians: the effects of prednisolone on the HPA-axis vs immunossupression

12.50-14.20

BREAK 

ESVIM/ISCAID

 ECVPT Congress

Myriam Hesta (BE)
How to improve success rate in obesity treatment

Megan Grobman (USA)
Aerodigestive disorders in dogs and cats

Karen Dirksen (NL)
New findings on copper storage disease and nutritional management of affected dogs

Megan Grobman (USA)
New diagnostic tools in the assessment of aerodigestive disorders in small animal medicine

Jonathan Mochel & Jessica Ward (USA)
RAAS modulation in veterinary cardiology: which is stronger - the light side or dark side of the force? 

BREAK 

TBD
Are EPA and DHA intake really helpful for adult cats?

Minna Rajamäki (FI)
Gastrointestinal contents as markers of reflux in bronchoalveolar lavage of dogs

Lionel Sebbag (IL)
Albumin as a biomarker for ocular insult: the blood-tear barrier from a clinical and pharmacological perspective

Jan Suchodolski (USA)
The lung-GUT-axis – role of the microbiome in dogs and cats

Karin Allenspach (USA)
GI biomarkers